-
Protease Inhibitor Cocktail for DFCP1–ATGL Lysates
2026-09-20
Preserve labile DFCP1–ATGL interactions and lipid-droplet proteins during extraction with a broad-spectrum, EDTA-containing formulation. The workflow combines practical cold-chain handling with assay-specific safeguards for Western blotting, Co-IP, imaging, and kinase studies.
-
Gramine, CUL3–MTDH, and Ferroptosis in TNBC
2026-09-19
A 2026 study identifies Gramine as a mechanistically defined ferroptosis inducer in triple-negative breast cancer through disruption of the CUL3–MTDH ubiquitination axis. Its combination of target-engagement assays, ferroptosis rescue experiments, genetic perturbation, and mouse models provides a useful framework for studying how MTDH stabilization can drive oxidative cancer-cell death.
-
MLN2238: Proteasome β5 Inhibition
2026-09-18
MLN2238 is a reversible proteasome β5 subunit inhibitor with nanomolar biochemical potency and broader proteasome-site inhibition at higher concentrations. Research findings connect MLN2238-mediated proteasome stress with ROS–JNK–CREB signaling, while product data support applications in multiple myeloma and lymphoma research.
-
Protein A/G Magnetic Co-IP/IP Kit for RNF8
2026-09-18
Use the Protein A/G Magnetic Co-IP/IP Kit to test native RNF8–DAPK1 complexes in ischemic-stroke models with rapid magnetic handling and clear controls. The workflow also supports antibody purification using magnetic beads and orthogonal validation of exosome-driven signaling mechanisms.
-
T-5224: Mapping AP-1 to Inflammation and Ferroptosis
2026-09-17
T-5224, a selective C-Fos/AP-1 inhibitor, offers a way to connect transcription-factor activity with inflammatory, osteoclastogenic, and ferroptotic phenotypes. This article presents a decision framework for choosing assays, interpreting pathway rescue, and separating established evidence from translational hypotheses.
-
Z-WEHD-FMK Workflow for Caspase Signaling
2026-09-17
Z-WEHD-FMK enables practical inhibition of inflammatory caspases in pyroptosis, inflammation, and Chlamydia pathogenesis workflows. This guide translates a recent HOXC8–caspase-1 study into assay choices, dosing steps, controls, and troubleshooting strategies.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-09-16
FITC-Concanavalin A is a fluorescent lectin conjugate for detecting accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cell, tissue, microscopy, and flow cytometry workflows. It should be used as a carbohydrate-binding probe rather than as a universal glycan marker or a specific protein-detection reagent.
-
NMDA in Excitotoxicity-to-Ferroptosis Assays
2026-09-16
NMDA (N-Methyl-D-aspartic acid) can connect receptor-driven calcium loading with oxidative and ferroptotic injury. This article presents a retina-informed assay framework for selecting readouts, controls, and interpretation strategies in excitotoxicity research.
-
Z-WEHD-FMK in Caspase-1 and Pyroptosis Research
2026-09-15
Z-WEHD-FMK provides a practical way to distinguish inflammatory caspase activity from downstream cell-death phenotypes in infection, inflammation, and cancer models. This guide connects a benchmark Chlamydia workflow with the recent HOXC8–caspase-1 study, emphasizing controls, assay selection, and troubleshooting.
-
Exosomal Egr2 Protects Neurons via the RNF8/DAPK1 Axis
2026-09-15
The reference study identifies BMSC-derived exosomal Egr2 as a regulator of neuronal injury after oxygen-glucose deprivation/reoxygenation, linking transcriptional activation of RNF8 with ubiquitination-related control of DAPK1. Its integrated use of exosome characterization, promoter assays, rescue experiments, and co-immunoprecipitation provides a mechanistic framework for studying paracrine neuroprotection, while the in vitro design leaves important questions about in vivo transferability.
-
Diphenyleneiodonium chloride in ROS Assays
2026-09-14
Diphenyleneiodonium chloride is a versatile redox perturbation tool for separating oxidase-dependent ROS production from cAMP-linked signaling. This practical guide connects DPI workflows to citrus pathogen-resistance research, cell-based pathway assays, and troubleshooting strategies that limit off-target interpretation.
-
miR-196a Drives EAC via the MYC/TERT/NFκB Axis
2026-09-14
A 2025 Molecular Oncology study identifies miR-196a as an active driver of aggressive esophageal adenocarcinoma behavior rather than merely a progression marker. By connecting NFKBIA, VCP, c-MYC, TERT, and NFκB signaling to epithelial-to-mesenchymal transition and motility, the work provides a mechanistic framework for testing pathway dependence in cancer research.
-
Western Secondary Antibody Dilution Buffer Guide
2026-09-13
Learn how to standardize secondary-antibody handling for cleaner, more reproducible Western blots in macrophage and atherosclerosis research. This guide connects practical reagent management with the NHE1/Olfr2 mechanism and shows when reuse, controls, and troubleshooting can improve assay efficiency.
-
Pentoxifylline in Leishmania and HTLV-1 Infections
2026-09-12
The 2008 reference paper synthesized mechanistic, patient-sample, and clinical evidence that Pentoxifylline can reduce pathological T-cell and cytokine responses in HTLV-1-associated myelopathy and leishmaniasis. Its central contribution was to frame cytokine down-modulation as a potential way to limit immune-mediated tissue injury without treating Pentoxifylline as a direct antimicrobial agent.
-
GSK-923295: Reliable CENP-E Assay Design
2026-09-11
Learn how GSK-923295, SKU A3450, can clarify mitotic arrest, chromosome-alignment defects, and growth-inhibition data in cell-based assays. This scenario-driven guide covers mechanism, controls, formulation, interpretation, and practical product-selection criteria for cancer research.